Most recent by Sarah Rodriguez, PharmD, BCPS
SPONSORED CONTENT
January 25, 2012
5 min read
Save
Brentuximab vedotin: A breakthrough for refractory CD30+ lymphomas
The introduction of rituximab in the 1990s revolutionized the treatment of CD20+ B-cell lymphomas.